LESLIE MAZUR: Open Payments
NPI 1568418432 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,278 in 103 payments from 18 companies in 2025. Trend: 2023 $3,158 · 2024 $3,055 · 2025 $2,278
Food & beverage: $2,278
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $484 |
| Galderma Laboratories, L.P. | 25 | $411 |
| Novartis Pharmaceuticals Corporation | 7 | $169 |
| GENZYME CORPORATION | 6 | $159 |
| REVANCE THERAPEUTICS, INC. | 1 | $150 |
| Amgen Inc. | 7 | $149 |
| UCB, Inc. | 4 | $139 |
| Janssen Biotech, Inc. | 5 | $114 |
| Arcutis Biotherapeutics, Inc. | 5 | $83 |
| LEO Pharma Inc. | 3 | $83 |
Products named: SKYRIZI, NEMLUVIO, DUPIXENT, RINVOQ, DAXXIFY, OTEZLA, Bimzelx, TREMFYA.
Industry payments across CO — which companies pay providers there.
